FarmaForce Limited (ASX:FFC) has delivered more evidence of its continued growth as Australia’s premier healthcare contract sales organisation (CSO) with its latest ASX announcement, showing a 100% increase in sales in Q3 FY19 compared to Q3 FY18. With a 57% compound annual growth rate (CAGR) … Continue reading FarmaForce ASX announcement shows continued market-leading sales growth